Skip to main content
Clinical Trials/NCT02219945
NCT02219945
Completed
Not Applicable

The Accuracy of the eNose in the Diagnostics and Monitoring of Treatment of Treatment-naive TB Patients

Tjip van der Werf1 site in 1 country389 target enrollmentNovember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary Tuberculosis Suspected
Sponsor
Tjip van der Werf
Enrollment
389
Locations
1
Primary Endpoint
diagnostic precision of electronic nose signal in pulmonary TB
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Electronic noses detecting patterns of volatile molecules have recently been introduced for different diagnostic purposes. The diagnostic accuracy of a prototype e-nose device (Bruins et al (2013) in Bangladesh showed sensitivity of 76.5-95.9% and specificity of 85.3-98.5%. Here the investigators test a production type point-of-care hand-held device with less detectors. The investigators explore factors such as food intake, smoking, and co-morbidity, as well as the impact of TB treatment, and address the question whether the device could help monitor disease and response to treatment.

Detailed Description

Study participants provide WIC and after time for consideration, when they approve, provide demographic anonymized data. The study population consists of six groups: Group 1 - 20 TB patients aged \> 18 yrs Group 2 - 20 non---TB patients \> 18 yrs (screened for TB - other conditions) Group 3 - 20 patients with a lung disease - no TB suspects (Lung Clinics in Yogyakarta,Indonesia; Group 4 - 50 apparently healthy matched controls Group 5 - 20 newly diagnosed TB patients enrolled before start of treatment, to be followed over time, until after end of treatment (8 months FU). Group 6 - 50 apparently healthy volunteers. Study participants breath normally by mouthpiece into the device using a nose clamp - for 5 min during each sampling. Electronic data are downloaded and transmitted by internet to Zutphen, Netherlands where data are processed to build the model.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
April 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Tjip van der Werf
Responsible Party
Sponsor Investigator
Principal Investigator

Tjip van der Werf

Professor

University Medical Center Groningen

Eligibility Criteria

Inclusion Criteria

  • age \>18yrs
  • voluntarily participating

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

diagnostic precision of electronic nose signal in pulmonary TB

Time Frame: 18 months

sensitivity and specificity of electronic nose signal in diagnosing and measuring response to treatment in pulmonary TB

Secondary Outcomes

  • measuring response to TB treatment over time with the electronic nose(18 months)

Study Sites (1)

Loading locations...

Similar Trials